Evidence map›Paper›PMID 29602833›Full record

ArticleJournal of the American Society of Nephrology : JASN2018

Post-Transplant Natural Antibodies Associate with Kidney Allograft Injury and Reduced Long-Term Survival.

Sarah B See, Olivier Aubert, Alexandre Loupy, Yokarla Veras, Xavier Lebreton, Baoshan Gao, Christophe Legendre, Dany Anglicheau, Emmanuel Zorn

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 41 citations in OpenAlex.

  1. Pretransplant natural antibody levels identify a subset of deceased donor kidney transplant recipients that benefit from infliximab induction.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Trial
  2. Trial
  3. Review
  4. Proceedings of the 2024 Transplant AI Symposium.Frontiers in transplantation · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Apelin/APJ-Manipulated CaMKK/AMPK/GSK3Oxidative medicine and cellular longevity · 2021
    Article
  11. Article
  12. Novel insights into non-HLA alloimmunity in kidney transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2020
    Review
  13. Article
  14. Antibodies against ARHGDIB are associated with long-term kidney graft loss.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Article
  15. Review
  16. Review
  17. Article
  18. New insights into immune mechanisms of antiperlecan/LG3 antibody production: Importance of T cells and innate B1 cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Sarah B SeeColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York.ORCID 0000-0002-4208-317X
Olivier AubertDepartment of Kidney Transplantation, Hopital Necker, Université Paris Descartes and Assistance Publique Hopitaux de Paris, Paris, France.
Alexandre LoupyDepartment of Kidney Transplantation, Hopital Necker, Université Paris Descartes and Assistance Publique Hopitaux de Paris, Paris, France.ORCID 0000-0003-3388-7747
Yokarla VerasColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York.
Xavier LebretonDepartment of Kidney Transplantation, Hopital Necker, Université Paris Descartes and Assistance Publique Hopitaux de Paris, Paris, France.
Baoshan GaoDepartment of Urology/Transplant Center, The First Hospital of Jilin University, Changchun, China.
Christophe LegendreDepartment of Kidney Transplantation, Hopital Necker, Université Paris Descartes and Assistance Publique Hopitaux de Paris, Paris, France.
Dany AnglicheauDepartment of Kidney Transplantation, Hopital Necker, Université Paris Descartes and Assistance Publique Hopitaux de Paris, Paris, France.
Emmanuel ZornColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, New York; ez2184@cumc.columbia.edu.
Hôpital Necker-Enfants Malades · FRColumbia University Irving Medical Center · USJilin University · CN

Funding

Innate B cell immunity and antibody-mediated rejection of human kidney allograftsR01AI123342 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Emmanuel Zorn · 2016 to 2026
$3.3M
NIAID NIH HHS R01 AI123342
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Graft SurvivalKidney TransplantationAdultAllograftsFemaleGraft RejectionHLA AntigensHumansImmunoglobulin GKaplan-Meier EstimateMaleMalondialdehydeMiddle AgedPostoperative PeriodPreoperative PeriodRetrospective StudiesHLA AntigensImmunoglobulin GMalondialdehydeDSAnatural antibodiesnatural polyreactive antibodiesnon-HLA antibodiesoxidation-specific epitopes

Identifiers

PMID29602833
PMCPMC6054349
OpenAlexW2794609186

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.